ASP7147 / Drais  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ASP7147 / Drais
NCT01896583: A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Completed
2
64
US
ASP7147, Placebo
Seldar Pharma, Inc.
Diarrhea Predominant Irritable Bowel Syndrome
03/14
07/14

Download Options